Company Status

In 2020, Implant Preservation Devices B.V. (IPD) was established, in cooperation with University Medical Center Leiden, the Netherlands, and NLC, The Health tech Venture Builder, to further develop a niche innovation, prepare for commercialisation and professional market launch. Due to the nature of this novelty product and the uniqueness in the problematic area of infection treatment with metal implants, the position of IPD will have an added value for any surgeon treating patients with PJI infection.
IPD expects market launch in 2025. In the meantime we focus on clinical evidence and prepare for CE-marking and FDA approval.